000 | 01701 a2200457 4500 | ||
---|---|---|---|
005 | 20250513064944.0 | ||
264 | 0 | _c19931105 | |
008 | 199311s 0 0 eng d | ||
022 | _a0065-4299 | ||
024 | 7 |
_a10.1007/BF01976211 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSordelli, D O | |
245 | 0 | 0 |
_aPiroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro. _h[electronic resource] |
260 |
_bAgents and actions _cMar 1993 |
||
300 |
_a196-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChemotactic Factors _xpharmacology |
650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
650 | 0 | 4 |
_aCopper _xadministration & dosage |
650 | 0 | 4 | _aCopper Sulfate |
650 | 0 | 4 |
_aCytochrome c Group _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEdema _xdrug therapy |
650 | 0 | 4 |
_aEdetic Acid _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aLung _xcytology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aPeroxidase _xmetabolism |
650 | 0 | 4 |
_aPiroxicam _xadministration & dosage |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xchemistry |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
700 | 1 | _aFontán, P A | |
700 | 1 | _aAmura, C R | |
773 | 0 |
_tAgents and actions _gvol. 38 _gno. 3-4 _gp. 196-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01976211 _zAvailable from publisher's website |
999 |
_c8212638 _d8212638 |